Cost-effectiveness of prospective red blood cell antigen matching to prevent alloimmunization among sickle cell patients (Q37136211)

18 August 2017

Cost-effectiveness of prospective red blood cell antigen matching to prevent alloimmunization among sickle cell patients (English)

1 reference

cost-effectiveness analysis

18 August 2017

0 references

1 reference

2

Paul M Ness

1 reference

18 August 2017

Seema Kacker

1

1 reference

18 August 2017

William J Savage

3

1 reference

18 August 2017

Kevin D Frick

4

1 reference

18 August 2017

R Sue Shirey

5

1 reference

18 August 2017

Karen E King

6

1 reference

18 August 2017

Aaron A R Tobian

7

1 reference

18 August 2017

21 May 2013

1 reference

18 August 2017

1 reference

18 August 2017

54

1 reference

18 August 2017

1

1 reference

18 August 2017

86-97

1 reference

Red blood cell alloimmunization in sickle cell disease: prevalence in 2010.

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3758770

Transfusion practices for patients with sickle cell disease at major academic medical centers participating in the Atlanta Sickle Cell Consortium.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3758770

Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3758770

Extended red blood cell antigen matching for transfusions in sickle cell disease: a review of a 14-year experience from a single center (CME).

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3758770

Does Medicare have an implicit cost-effectiveness threshold?

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3758770

Blood bank management of sickle cell patients at comprehensive sickle cell centers

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3758770

Pharmaco-economics of blood transfusion safety: review of the available evidence

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3758770

Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3758770

Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3758770

An introduction to Markov modelling for economic evaluation

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3758770

The differentiation of delayed serologic and delayed hemolytic transfusion reactions: incidence, long-term serologic findings, and clinical significance

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3758770

Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3758770

Transfusion protocols for patients with sickle cell disease: working toward consensus?

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3758770

The prevention and management of alloimmunization in sickle cell disease: the benefit of extended phenotypic matching of red blood cells.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3758770

Antigen-matched red blood cell transfusions for patients with sickle cell disease at The Johns Hopkins Hospital

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3758770

Transfusion management of patients with sickle cell disease: the continuing dilemma.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3758770

The cost of health care for children and adults with sickle cell disease

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3758770

Stochastic modeling of human RBC alloimmunization: evidence for a distinct population of immunologic responders.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3758770

Alloimmunization to red blood cell antigens affects clinical outcomes in liver transplant patients

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3758770

Duffy and Kidd blood group antigens: minor histocompatibility antigens involved in renal allograft rejection?

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3758770

Allosensitization in patients receiving multiple blood transfusions.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3758770

Phenotype matching of donor red blood cell units for nonalloimmunized sickle cell disease patients: a survey of 1182 North American laboratories

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3758770

Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implications

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3758770

Cost-effectiveness of hydroxyurea in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3758770

To match or not to match: the question for chronically transfused patients with sickle cell anemia.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3758770

Transfusion protocol for patients with sickle hemoglobinopathies at Children's National Medical Center

3 September 2018

1 reference

12 December 2020

Experience with donors matched for minor blood group antigens in patients with sickle cell anemia who are receiving chronic transfusion therapy

1 reference

12 December 2020

Antigen-matched donor blood in the transfusion management of patients with sickle cell disease

1 reference

12 December 2020

Population estimates of sickle cell disease in the U.S.

1 reference

12 December 2020

Identifiers

DOI

10.1111/TRF.12250

1 reference

18 August 2017

1 reference

18 August 2017

PubMed publication ID

23692415

1 reference